866-997-4948(US-Canada Toll Free)

Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 124 Pages

Notes:
Sales, means the sales volume of Chronic Idiopathic Constipation (CIC) Drugs
Revenue, means the sales value of Chronic Idiopathic Constipation (CIC) Drugs

This report studies sales (consumption) of Chronic Idiopathic Constipation (CIC) Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Actavis
Chugai Pharmaceutical
Ferring International Center S.A.
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
Roche Holding AG
Sanofi
Bayer AG
Salix Pharmaceuticals Ltd
Sucampo Pharmaceuticals Inc
Ironwood Pharmaceuticals
Progenics Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Chronic Idiopathic Constipation (CIC) Drugs in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Lubiprostone
Linaclotide
Others
Split by applications, this report focuses on sales, market share and growth rate of Chronic Idiopathic Constipation (CIC) Drugs in each application, can be divided into
Hospitals & Clinics
Ambulatory Surgical Centres
Long Term Care Centres
Others

Table of Contents

Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Report 2017
1 Chronic Idiopathic Constipation (CIC) Drugs Overview
1.1 Product Overview and Scope of Chronic Idiopathic Constipation (CIC) Drugs
1.2 Classification of Chronic Idiopathic Constipation (CIC) Drugs
1.2.1 Lubiprostone
1.2.2 Linaclotide
1.2.3 Others
1.3 Application of Chronic Idiopathic Constipation (CIC) Drugs
1.3.1 Hospitals & Clinics
1.3.2 Ambulatory Surgical Centres
1.3.3 Long Term Care Centres
1.3.4 Others
1.4 Chronic Idiopathic Constipation (CIC) Drugs Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Chronic Idiopathic Constipation (CIC) Drugs (2012-2022)
1.5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Growth Rate (2012-2022)

2 Global Chronic Idiopathic Constipation (CIC) Drugs Competition by Manufacturers, Type and Application
2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Competition by Manufacturers
2.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Share by Manufacturers (2012-2017)
2.2 Global Chronic Idiopathic Constipation (CIC) Drugs (Volume and Value) by Type
2.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Chronic Idiopathic Constipation (CIC) Drugs (Volume and Value) by Regions
2.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Regions (2012-2017)
2.3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Regions (2012-2017)
2.4 Global Chronic Idiopathic Constipation (CIC) Drugs (Volume) by Application

3 United States Chronic Idiopathic Constipation (CIC) Drugs (Volume, Value and Sales Price)
3.1 United States Chronic Idiopathic Constipation (CIC) Drugs Sales and Value (2012-2017)
3.1.1 United States Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Chronic Idiopathic Constipation (CIC) Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Chronic Idiopathic Constipation (CIC) Drugs Sales Price Trend (2012-2017)
3.2 United States Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Manufacturers
3.3 United States Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Type
3.4 United States Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Application

4 China Chronic Idiopathic Constipation (CIC) Drugs (Volume, Value and Sales Price)
4.1 China Chronic Idiopathic Constipation (CIC) Drugs Sales and Value (2012-2017)
4.1.1 China Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Chronic Idiopathic Constipation (CIC) Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Chronic Idiopathic Constipation (CIC) Drugs Sales Price Trend (2012-2017)
4.2 China Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Manufacturers
4.3 China Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Type
4.4 China Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Application

5 Europe Chronic Idiopathic Constipation (CIC) Drugs (Volume, Value and Sales Price)
5.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales and Value (2012-2017)
5.1.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Price Trend (2012-2017)
5.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Manufacturers
5.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Type
5.4 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Application

6 Japan Chronic Idiopathic Constipation (CIC) Drugs (Volume, Value and Sales Price)
6.1 Japan Chronic Idiopathic Constipation (CIC) Drugs Sales and Value (2012-2017)
6.1.1 Japan Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Chronic Idiopathic Constipation (CIC) Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Chronic Idiopathic Constipation (CIC) Drugs Sales Price Trend (2012-2017)
6.2 Japan Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Manufacturers
6.3 Japan Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Type
6.4 Japan Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Application
7 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Type
7.4 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Application
8 India Chronic Idiopathic Constipation (CIC) Drugs (Volume, Value and Sales Price)
8.1 India Chronic Idiopathic Constipation (CIC) Drugs Sales and Value (2012-2017)
8.1.1 India Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Chronic Idiopathic Constipation (CIC) Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Chronic Idiopathic Constipation (CIC) Drugs Sales Price Trend (2012-2017)
8.2 India Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Manufacturers
8.3 India Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Type
8.4 India Chronic Idiopathic Constipation (CIC) Drugs Sales and Market Share by Application

9 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Analysis
9.1 Actavis
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
9.1.2.1 Lubiprostone
9.1.2.2 Linaclotide
9.1.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Chugai Pharmaceutical
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
9.2.2.1 Lubiprostone
9.2.2.2 Linaclotide
9.2.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Ferring International Center S.A.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
9.3.2.1 Lubiprostone
9.3.2.2 Linaclotide
9.3.3 Ferring International Center S.A. Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Synergy Pharmaceuticals
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
9.4.2.1 Lubiprostone
9.4.2.2 Linaclotide
9.4.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Pfizer
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
9.5.2.1 Lubiprostone
9.5.2.2 Linaclotide
9.5.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 GlaxoSmithKline
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
9.6.2.1 Lubiprostone
9.6.2.2 Linaclotide
9.6.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Roche Holding AG
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
9.7.2.1 Lubiprostone
9.7.2.2 Linaclotide
9.7.3 Roche Holding AG Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Sanofi
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
9.8.2.1 Lubiprostone
9.8.2.2 Linaclotide
9.8.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Bayer AG
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
9.9.2.1 Lubiprostone
9.9.2.2 Linaclotide
9.9.3 Bayer AG Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Salix Pharmaceuticals Ltd
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification
9.10.2.1 Lubiprostone
9.10.2.2 Linaclotide
9.10.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Sucampo Pharmaceuticals Inc
9.12 Ironwood Pharmaceuticals
9.13 Progenics Pharmaceuticals

10 Chronic Idiopathic Constipation (CIC) Drugs Maufacturing Cost Analysis
10.1 Chronic Idiopathic Constipation (CIC) Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Chronic Idiopathic Constipation (CIC) Drugs
10.3 Manufacturing Process Analysis of Chronic Idiopathic Constipation (CIC) Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Chronic Idiopathic Constipation (CIC) Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Chronic Idiopathic Constipation (CIC) Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (2017-2022)
14.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price and Trend Forecast (2017-2022)
14.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *